HOME >> BIOLOGY >> NEWS
A&M researcher studying genes of mosquitoes

COLLEGE STATION Texas A&M University researchers are studying the genes of the mosquito species, Aedes aegypti, the carrier for both dengue and yellow fever, hoping to keep deadly mosquito-borne diseases at bay.

Dr. Patricia Pietrantonio, associate professor of entomology with the Texas Agricultural Experiment Station, is leading a team of researchers studying the hormone-controlled mechanism by which mosquitoes excrete waste.

"This research has far-reaching implications for the discovery of new alternatives for insect control," Pietrantonio said.

Presently, a human vaccine for yellow fever exists, but none for dengue.

The researchers are hoping the studies will reveal how the female mosquito's system produces a diuretic response during and after a blood meal. Aedes aegypti feed during the daytime and need a blood meal to reproduce. The blood meal triggers vitellogenesis (formation of the yolk of an egg) and oogenesis (egg formation).

"They feed on humans and animals, and if the blood meal is successful, then reproduction begins," Pietrantonio said. "They can lay eggs for one to two days, and then they can feed again. The reproductive potential of the female is quite significant."

As mosquitoes feed, they begin excreting a clear liquid very quickly.

"Diuresis, or the production of urine, is very fast. If they are still engorged, they fly very poorly and susceptible to being slapped by a human or eaten by a predator," she explained.

"We want to know how the mosquito gets rid of all this water so fast. It is very complex process."

To do so, researchers are cloning mosquito genes and studying cell receptors, the proteins in the cell membranes involved in the transfer of information from one area of the cell to another. The process is regulated by hormones.

Hormones are released
'"/>

Contact: Dr. Patricia Pietrantonio
p-pietrantonio@tamu.edu
979-845-9728
Texas A&M University - Agricultural Communications
24-Mar-2004


Page: 1 2

Related biology news :

1. Belgian researchers explore revolutionary approach to angiogenesis
2. Award winning researchers reveal potential new role for Glivec
3. University of Alberta researcher looks for clues to mysterious disease
4. $7.5 Million grant to Yale researchers for role of viruses in cancer
5. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
6. Joslin researchers clarify mechanisms for beta-cell formation
7. Pioneering AIDS researcher to speak at UH
8. Defensive action by influenza viruses demonstrated by Hebrew university researcher
9. Virginia Tech researchers to release findings on Smith River Project
10. Molecular motor myosin VI moves hand over hand, researchers say
11. Tiny molecules have big potential as cancer drugs, Stanford researcher believes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/11/2019)... ... July 11, 2019 , ... ... first on-site Legionella DNA test, today announced a partnership with LiquiTech, a ... , Through this strategic partnership, LiquiTech will integrate Spartan’s innovative environmental DNA ...
(Date:7/5/2019)... VIEW, Calif. (PRWEB) , ... July 05, 2019 ... ... partnering with Microsoft to bring its patented Tractus™ Platform to governments around the ... will bring cutting edge technology and point of care solutions to operating theatres ...
(Date:6/19/2019)... (PRWEB) , ... June 19, 2019 , ... Dahryn Trivedi, ... physicochemical properties of Cefazolin Sodium, antibiotic which can prove to be beneficial for treating ... 519% increase in residue amount , Over 68% decrease in weight ...
Breaking Biology News(10 mins):
(Date:7/9/2019)... ... July 08, 2019 , ... Balluff has been named ... as the 2019 Innovative Product of the Year which highlights cutting-edge advancements and ... Sensors Expo & Conference 2019, held this week in San Jose, ...
(Date:6/26/2019)... ... , ... Alice Branton today released research results from preclinical trials on the ... can prove to be beneficial for treating Hypomagnesemia. , The preclinical trial shows:, ... size , Over 142% increase in particle size , Over ...
(Date:6/18/2019)... ... 18, 2019 , ... Personalized Stem Cells, Inc (“PSC”), a human ... FDA for use of a person’s own adipose-derived stem cells to treat their osteoarthritis. ... knee. This IND is the first of several planned clinical trials which will ...
(Date:6/11/2019)... ... June 10, 2019 , ... ... network with the appointment of Biofeedback Tech Ltd as its authorised ... an essential part of many therapeutic treatments and clinical assessment protocols to treat ...
Breaking Biology Technology:
Cached News: